logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Jump to: Company in focus, Offsprings
Parent entities and officers 7
  • 1
    Andrew, Jonathan Charles
    Born in May 1967
    Individual (20 offsprings)
    Officer
    2026-03-16 ~ now
    OF - Director → CIF 0
  • 2
    Stott, Paul William
    Born in January 1971
    Individual (4 offsprings)
    Officer
    2019-04-24 ~ now
    OF - Director → CIF 0
    Mr Paul William Stott
    Born in January 1971
    Individual (4 offsprings)
    Person with significant control
    2026-01-03 ~ 2026-03-16
    PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50% → CIF 0
  • 3
    Jones, Harry Robert James
    Born in April 1990
    Individual (8 offsprings)
    Officer
    2026-03-16 ~ now
    OF - Director → CIF 0
  • 4
    De Matas, Marcel
    Born in February 1973
    Individual (4 offsprings)
    Officer
    2015-02-17 ~ now
    OF - Director → CIF 0
    Mr Marcel De Matas
    Born in February 1973
    Individual (4 offsprings)
    Person with significant control
    2016-04-06 ~ 2026-03-16
    PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50% → CIF 0
  • 5
    Dickinson, Paul Alfred
    Born in March 1968
    Individual (3 offsprings)
    Officer
    2015-02-17 ~ now
    OF - Director → CIF 0
    Mr Paul Alfred Dickinson
    Born in March 1968
    Individual (3 offsprings)
    Person with significant control
    2016-04-06 ~ 2026-03-16
    PE - Ownership of voting rights - More than 25% but not more than 50% → CIF 0
    PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
  • 6
    BGF NOMINEES LIMITED
    10007355
    13-15, York Buildings, London, England
    Active Corporate (6 parents, 70 offsprings)
    Person with significant control
    2026-03-16 ~ now
    PE - Ownership of voting rights - More than 25% but not more than 50% → CIF 0
    PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
  • 7
    ALEVA HOLDINGS LIMITED
    11937723
    15, Manor Close, Wilmslow, United Kingdom
    Active Corporate (1 parent, 1 offspring)
    Person with significant control
    2019-04-24 ~ 2026-03-03
    PE - Ownership of voting rights - More than 25% but not more than 50% → CIF 0
parent relation
Company in focus

SEDA PHARMA DEVELOPMENT SERVICES LTD.

Period: 2015-02-17 ~ now
Company number: 09442533
Registered name
SEDA PHARMA DEVELOPMENT SERVICES LTD. - now
Standard Industrial Classification
72190 - Other Research And Experimental Development On Natural Sciences And Engineering
Brief company account
Property, Plant & Equipment
3,715,811 GBP2025-03-31
3,696,384 GBP2024-03-31
Fixed Assets - Investments
100 GBP2025-03-31
100 GBP2024-03-31
Fixed Assets
3,715,911 GBP2025-03-31
3,696,484 GBP2024-03-31
Debtors
9,462,286 GBP2025-03-31
6,306,847 GBP2024-03-31
Cash at bank and in hand
518,968 GBP2025-03-31
1,786,428 GBP2024-03-31
Current Assets
9,981,254 GBP2025-03-31
8,093,275 GBP2024-03-31
Net Current Assets/Liabilities
8,280,357 GBP2025-03-31
6,782,546 GBP2024-03-31
Total Assets Less Current Liabilities
11,996,268 GBP2025-03-31
10,479,030 GBP2024-03-31
Net Assets/Liabilities
4,369,206 GBP2025-03-31
3,294,261 GBP2024-03-31
Equity
Called up share capital
150 GBP2025-03-31
150 GBP2024-03-31
Share premium
124,950 GBP2025-03-31
124,950 GBP2024-03-31
Retained earnings (accumulated losses)
4,244,106 GBP2025-03-31
3,169,161 GBP2024-03-31
Equity
4,369,206 GBP2025-03-31
3,294,261 GBP2024-03-31
Average Number of Employees
342024-04-01 ~ 2025-03-31
342023-04-01 ~ 2024-03-31
Property, Plant & Equipment - Gross Cost
Land and buildings
3,495,551 GBP2025-03-31
3,495,551 GBP2024-03-31
Other
995,722 GBP2025-03-31
762,872 GBP2024-03-31
Property, Plant & Equipment - Gross Cost
4,491,273 GBP2025-03-31
4,258,423 GBP2024-03-31
Property, Plant & Equipment - Other Disposals
Land and buildings
0 GBP2024-04-01 ~ 2025-03-31
Other
-17,363 GBP2024-04-01 ~ 2025-03-31
Property, Plant & Equipment - Other Disposals
-17,363 GBP2024-04-01 ~ 2025-03-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Land and buildings
221,564 GBP2025-03-31
151,653 GBP2024-03-31
Other
553,898 GBP2025-03-31
410,386 GBP2024-03-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
775,462 GBP2025-03-31
562,039 GBP2024-03-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Land and buildings
69,911 GBP2024-04-01 ~ 2025-03-31
Other
150,167 GBP2024-04-01 ~ 2025-03-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
220,078 GBP2024-04-01 ~ 2025-03-31
Property, Plant & Equipment - Other Disposals/Decrease in Depreciation & Impairment
Land and buildings
0 GBP2024-04-01 ~ 2025-03-31
Other
-6,655 GBP2024-04-01 ~ 2025-03-31
Property, Plant & Equipment - Other Disposals/Decrease in Depreciation & Impairment
-6,655 GBP2024-04-01 ~ 2025-03-31
Property, Plant & Equipment
Land and buildings
3,273,987 GBP2025-03-31
3,343,898 GBP2024-03-31
Other
441,824 GBP2025-03-31
352,486 GBP2024-03-31
Investments in group undertakings and participating interests
100 GBP2025-03-31
100 GBP2024-03-31
Trade Debtors/Trade Receivables
Current
620,604 GBP2025-03-31
609,742 GBP2024-03-31
Amounts Owed By Related Parties
8,703,803 GBP2025-03-31
Current
5,192,549 GBP2024-03-31
Other Debtors
Amounts falling due within one year
137,879 GBP2025-03-31
504,556 GBP2024-03-31
Bank Borrowings/Overdrafts
Current
355,829 GBP2025-03-31
221,084 GBP2024-03-31
Trade Creditors/Trade Payables
Current
87,530 GBP2025-03-31
289,748 GBP2024-03-31
Other Taxation & Social Security Payable
Current
96,520 GBP2025-03-31
171,004 GBP2024-03-31
Other Creditors
Current
1,161,018 GBP2025-03-31
628,893 GBP2024-03-31
Creditors
Current, Amounts falling due within one year
1,700,897 GBP2025-03-31
Bank Borrowings/Overdrafts
Non-current
6,896,238 GBP2025-03-31
6,552,337 GBP2024-03-31
Other Creditors
Non-current
86,847 GBP2025-03-31
0 GBP2024-03-31
Creditors
Current
6,983,085 GBP2025-03-31
6,552,337 GBP2024-03-31
Par Value of Share
Class 1 ordinary share
1 GBP2024-04-01 ~ 2025-03-31
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
48 shares2025-03-31
48 shares2024-03-31
Par Value of Share
Class 2 ordinary share
1 GBP2024-04-01 ~ 2025-03-31
Number of Shares Issued (Fully Paid)
Class 2 ordinary share
52 shares2025-03-31
52 shares2024-03-31
Par Value of Share
Class 3 ordinary share
1 GBP2024-04-01 ~ 2025-03-31
Number of Shares Issued (Fully Paid)
Class 3 ordinary share
24 shares2025-03-31
24 shares2024-03-31
Par Value of Share
Class 4 ordinary share
1 GBP2024-04-01 ~ 2025-03-31
Number of Shares Issued (Fully Paid)
Class 4 ordinary share
26 shares2025-03-31
26 shares2024-03-31
Equity
Called up share capital
150 GBP2025-03-31
150 GBP2024-03-31
Future Minimum Lease Payments Under Non-cancellable Operating Leases
125,385 GBP2025-03-31
Related profiles found in government register
  • SEDA PHARMA DEVELOPMENT SERVICES LTD.
    Info
    Registered number 09442533
    Unit 4 Oakfield Road Cheadle Royal Business Park, Cheadle, Stockport, Greater Manchester SK8 3GX
    PRIVATE LIMITED COMPANY incorporated on 2015-02-17 (11 years 2 months). The status of the company number is Active.
    The last date of confirmation statement was made at 2026-02-17
    CIF 0
  • SEDA PHARMA DEVELOPMENT SERVICES LTD
    S
    Registered number missing
    Unit 4, Oakfield Road, Cheadle Royal Business Park, Cheadle, Stockport, Greater Manchester, England, SK8 3GX
    Limited Company
    CIF 1
child relation
Offspring entities and appointments 1
  • 1
    SEDA CLINICAL MANUFACTURING SERVICES LTD.
    14845445
    Unit 4 Oakfield Road, Cheadle Royal Business Park, Cheadle, Stockport, Greater Manchester, England
    Active Corporate (4 parents)
    Person with significant control
    2023-05-04 ~ now
    CIF 1 - Ownership of voting rights - 75% or more → OE
    CIF 1 - Has significant influence or control as a member of a firm → OE
    CIF 1 - Ownership of shares – 75% or more → OE
    CIF 1 - Right to appoint or remove directors as a member of a firm → OE

qrcode

Privacy notice

Terms and conditions

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 22 April 2026 and licensed under the Open Government Licence v3.0.